Sign In
Buy PIII
$10.05
-2.74 (-21.42%)
At Close: Jun 03, 2026
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
12:12pm, Friday, 23'rd May 2025
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
P3 Health Partners Inc. (PIII) Q1 2025 Earnings Call Transcript
10:37pm, Thursday, 15'th May 2025
P3 Health Partners Inc. (NASDAQ:PIII ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Ryan Halstead - Managing Director, Gilmartin Group LLC, IR Aric Coffman - CEO Leif
P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates
06:36pm, Thursday, 15'th May 2025
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.28 per share versus the Zacks Consensus Estimate of a loss of $5. This compares to loss of $8 per share a year ago.
P3 Health Partners Announces First Quarter 2025 Results
04:18pm, Thursday, 15'th May 2025
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its
P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar?
07:55am, Wednesday, 16'th Apr 2025
P3 Health Partners (PIII) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength d
P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference
08:05am, Wednesday, 02'nd Apr 2025
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate
P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call Transcript
08:30pm, Thursday, 27'th Mar 2025
P3 Health Partners Inc. (NASDAQ:PIII ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Ryan Halsted - IR Aric Coffman - CEO Leif Pedersen - CFO Amir Bacchus - Chief Med
P3 Health Partners Inc. (PIII) Reports Q4 Loss, Lags Revenue Estimates
06:51pm, Thursday, 27'th Mar 2025
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.22 per share a year ago.
P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results
04:22pm, Thursday, 27'th Mar 2025
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced it
P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27
04:05pm, Thursday, 13'th Mar 2025
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans t
P3 Health Partners (PIII) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
10:56am, Wednesday, 05'th Mar 2025
P3 Health Partners (PIII) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could
P3 Health Partners to Participate in the TD Cowen 45th Annual Health Care Conference
08:00am, Wednesday, 19'th Feb 2025
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
05:30pm, Monday, 10'th Feb 2025
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of P3 Health Partners Inc. (NASDAQ: PIII) breach
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
04:16pm, Thursday, 19'th Dec 2024
NEW YORK , Dec. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of P3 Health Partners Inc. (NASDAQ: PIII) breached
P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
08:00am, Wednesday, 27'th Nov 2024
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced tha
